Ocular Manifestations of COVID-19 Infection

The eyes, which were not previously the subject of investigation, have emerged as one of the more intriguing aspect of COVID-19 infection. The probable pathways for SARS-CoV-2 infection through the eyes are either through the tear film and draining tear ducts leading to the upper respiratory tract and gastrointestinal tract, or through the conjunctiva into limbal superficial cells into the inner eye, where distribution via the blood or nervous system appears to be possible. Virus pathogenesis through tear and conjunctiva has been established in animal models of several coronavirus eye diseases, and preliminary research have shown that SARS-CoV-2 may do the same in humans. Given that COVID-19 cases have reached pandemic proportions and are on the rise, it is vital to recognize the illness’s ocular manifestations and avert potentially vision-threatening effects. Coronaviruses may be transmitted between animals and humans through evolution, therefore investigating them in animal models could be crucial in the future to discover further elements of ocular involvement. It is recommended that health care and individual personnel take steps to avoid infection and limit viral transmission. More study is needed to understand the transmission pathways and the alternatives for COVID-19 prevention and therapy disseminated through the ocular surfaces for prompt recovery of the patients.

[1]  S. A. Rasoulinejad,et al.  Updates on Coronavirus-Related Ocular Manifestations: From the Past to COVID-19 Pandemic , 2022, Archives of Pediatric Infectious Diseases.

[2]  Yueyang Zhong,et al.  Ocular manifestations in COVID-19 patients: A systematic review and meta-analysis , 2021, Travel Medicine and Infectious Disease.

[3]  R. Malik,et al.  Corneal confocal microscopy identifies corneal nerve fibre loss and increased dendritic cells in patients with long COVID , 2021, British Journal of Ophthalmology.

[4]  Vigil James,et al.  Young man with a diffuse rash and red eyes after recovery from COVID‐2019 , 2021, Journal of the American College of Emergency Physicians open.

[5]  D. Brodie,et al.  Post-acute COVID-19 syndrome , 2021, Nature Medicine.

[6]  M. Lako,et al.  In the eye of the storm: SARS‐CoV‐2 infection and replication at the ocular surface? , 2021, Stem cells translational medicine.

[7]  P. Collignon,et al.  SARS-CoV-2: eye protection might be the missing key , 2021, The Lancet Microbe.

[8]  N. Sharma,et al.  COVID-19 and Eye: A Review of Ophthalmic Manifestations of COVID-19 , 2021, Indian journal of ophthalmology.

[9]  P. Hosseinpour,et al.  Conjunctivitis and other ocular manifestation following COVID-19; updated information about transmission of COVID-19 by eye , 2021, Immunopathologia Persa.

[10]  K. Sun,et al.  Atlas of ACE2 gene expression reveals novel insights into transmission of SARS-CoV-2 , 2020, Heliyon.

[11]  C. Newton-Cheh,et al.  Case Series of Multisystem Inflammatory Syndrome in Adults Associated with SARS-CoV-2 Infection — United Kingdom and United States, March–August 2020 , 2020, MMWR. Morbidity and mortality weekly report.

[12]  P. Leprince,et al.  Coronavirus Disease 2019 Acute Myocarditis and Multisystem Inflammatory Syndrome in Adult Intensive and Cardiac Care Units , 2020, Chest.

[13]  R. Dana,et al.  Clinical and Prodromal Ocular Symptoms in Coronavirus Disease: A Systematic Review and Meta-Analysis , 2020, Investigative ophthalmology & visual science.

[14]  Z. Ozturker,et al.  Conjunctivitis as sole symptom of COVID-19: A case report and review of literature , 2020, European journal of ophthalmology.

[15]  C. Azevedo,et al.  Myelin Oligodendrocyte Glycoprotein Antibody–Associated Optic Neuritis and Myelitis in COVID-19 , 2020, Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society.

[16]  J. Alió,et al.  COVID-19 Disease and Ophthalmology: An Update , 2020, Ophthalmology and Therapy.

[17]  Huimin Yu,et al.  Ocular manifestations and clinical characteristics of 535 cases of COVID‐19 in Wuhan, China: a cross‐sectional study , 2020, Acta ophthalmologica.

[18]  H. Flynn,et al.  Clinical and Perioperative Management in Ophthalmology During the COVID-19 Pandemic. , 2020, International ophthalmology clinics.

[19]  S. Priglinger,et al.  COVID-19: Ophthalmological Aspects of the SARS-CoV 2 Global Pandemic , 2020, Klinische Monatsblätter für Augenheilkunde.

[20]  E. d’Aloja,et al.  The Ocular Surface and the Coronavirus Disease 2019: Does a Dual ‘Ocular Route’ Exist? , 2020, Journal of clinical medicine.

[21]  S. Z. Scalinci,et al.  Conjunctivitis can be the only presenting sign and symptom of COVID-19 , 2020, IDCases.

[22]  Ting Huang,et al.  Ocular manifestations of a hospitalised patient with confirmed 2019 novel coronavirus disease , 2020, British Journal of Ophthalmology.

[23]  Kaili Wu,et al.  Characteristics of Ocular Findings of Patients With Coronavirus Disease 2019 (COVID-19) in Hubei Province, China , 2020, JAMA ophthalmology.

[24]  Zhijie Li,et al.  The possibility of COVID‐19 transmission from eye to nose , 2020, Acta ophthalmologica.

[25]  R. Agrawal,et al.  Can the Coronavirus Disease 2019 (COVID-19) Affect the Eyes? A Review of Coronaviruses and Ocular Implications in Humans and Animals , 2020, Ocular immunology and inflammation.

[26]  H. Gao,et al.  Ocular conjunctival inoculation of SARS-CoV-2 can cause mild COVID-19 in rhesus macaques , 2020, Nature Communications.

[27]  G. Herrler,et al.  SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor , 2020, Cell.

[28]  J. Tong,et al.  Evaluation of coronavirus in tears and conjunctival secretions of patients with SARS‐CoV‐2 infection , 2020, Journal of medical virology.

[29]  L. Girardi,et al.  The Current State of Animal Models in Research: A Review. , 2019, International journal of surgery.

[30]  Joshua C. Johnson,et al.  New Insights Into Marburg Virus Disease Pathogenesis in the Rhesus Macaque Model. , 2018, The Journal of infectious diseases.

[31]  N. Ziółkowska,et al.  Feline Infectious Peritonitis: Immunohistochemical Features of Ocular Inflammation and the Distribution of Viral Antigens in Structures of the Eye , 2017, Veterinary pathology.

[32]  H. Shimoda,et al.  Characterization of canine coronavirus spread among domestic dogs in Vietnam , 2016, The Journal of veterinary medical science.

[33]  M. Montazeri,et al.  The Association Between Primary Open Angle Glaucoma and Clustered Components of Metabolic Syndrome , 2015, The open ophthalmology journal.

[34]  S. Hosseini,et al.  Prevalence of age-related macular degeneration among the elderly , 2015, Caspian journal of internal medicine.

[35]  D. Squarre,et al.  Positive Immunolabelling for Feline Infectious Peritonitis in an African Lion (Panthera leo) with Bilateral Panuveitis , 2015, Journal of Comparative Pathology.

[36]  M. Chin,et al.  Identification of α-fodrin as an autoantigen in experimental coronavirus retinopathy (ECOR) , 2014, Journal of Neuroimmunology.

[37]  J. Stiles Ocular manifestations of feline viral diseases , 2013, The Veterinary Journal.

[38]  A. Ericsson,et al.  A brief history of animal modeling. , 2013, Missouri medicine.

[39]  L. Sandmeyer,et al.  Positive immunostaining for feline infectious peritonitis (FIP) in a Sphinx cat with cutaneous lesions and bilateral panuveitis , 2013, Veterinary ophthalmology.

[40]  P. Woo,et al.  Coronavirus Diversity, Phylogeny and Interspecies Jumping , 2009, Experimental biology and medicine.

[41]  N. Pedersen A review of feline infectious peritonitis virus infection: 1963–2008 , 2009, Journal of Feline Medicine & Surgery.

[42]  K. Mihindukulasuriya,et al.  Identification of a Novel Coronavirus from a Beluga Whale by Using a Panviral Microarray , 2008, Journal of Virology.

[43]  M. Chin,et al.  Experimental coronavirus retinopathy (ECOR): Retinal degeneration susceptible mice have an augmented interferon and chemokine (CXCL9, CXCL10) response early after virus infection , 2007, Journal of Neuroimmunology.

[44]  P. Jahrling,et al.  Pathologic findings associated with delayed death in nonhuman primates experimentally infected with Zaire Ebola virus. , 2007, The Journal of infectious diseases.

[45]  T. Slezak,et al.  Cynomolgus Macaque as an Animal Model for Severe Acute Respiratory Syndrome , 2006, PLoS medicine.

[46]  M. Chin,et al.  Retinal degeneration in experimental coronavirus retinopathy (ECOR) is associated with increased TNF-α, soluble TNFR2 and altered TNF-α signaling , 2005, Journal of Neuroimmunology.

[47]  Yun Wang,et al.  The Critical Role of IFN-γ in Experimental Coronavirus Retinopathy , 2003 .

[48]  B. Detrick,et al.  Blood–retinal barrier breakdown in experimental coronavirus retinopathy: association with viral antigen, inflammation, and VEGF in sensitive and resistant strains , 2001, Journal of Neuroimmunology.

[49]  Y. Wang,et al.  The role of apoptosis within the retina of coronavirus-infected mice. , 2000, Investigative ophthalmology & visual science.

[50]  D. Sullivan,et al.  Effect of sialodacryoadenitis virus exposure on acinar epithelial cells from the rat lacrimal gland. , 1997, Ocular immunology and inflammation.

[51]  K. Hök Morbidity, Mortality and Coronavirus Antigen in Previously Coronavirus Free Kittens Placed in Two Catteries with Feline Infectious Peritonitis , 1993, Acta Veterinaria Scandinavica.

[52]  B. Detrick,et al.  Coronavirus (JHM) Replication within the Retina: Analysis of Cell Tropism in Mouse Retinal Cell Cultures , 1993, Virology.

[53]  K. Hök Demonstration of feline infectious peritonitis virus in conjunctival epithelial cells from cats , 1989, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[54]  THE WORLD HEALTH ORGANIZATION , 1954 .

[55]  B. Patel,et al.  Ophthalmic Manifestations Of Coronavirus (COVID-19) , 2020 .

[56]  M. Burnier,et al.  Genetic predisposition to coronavirus-induced retinal disease. , 1996, Investigative ophthalmology & visual science.

[57]  C. Hamel,et al.  Murine coronavirus induces an acute and long-lasting disease of the retina. , 1990, Laboratory investigation; a journal of technical methods and pathology.